GLP-1 side effects: what the studies say vs. TikTok reassurance

What did @gcbelfast actually say?

This is where things get strange. The transcript attributed to this video is not about GLP-1 side effects at all. The words transcribed appear to be song lyrics, something about a river, a gun, and spending the good, none of which maps to the caption's promise of discussing "phantom hunger," "3PM brain fog," or "sulphur burps." There is a significant mismatch between what the caption describes and what the transcript contains.

It is possible the transcription tool picked up background audio, a song playing during the video, or experienced a processing error. We cannot fact-check claims that were not actually captured in the transcript. What we can do is fact-check the claims the caption explicitly telegraphs, because those are the ideas the creator is publicly promoting to 326,700 viewers.

Does the science back up the caption's framing?

The caption frames GLP-1 side effects as a normal adaptation process: "they don't mean anything's gone wrong, just that your body's adapting." That framing is mostly reasonable but requires some nuance. It is not wrong, but it is incomplete in ways that matter.

GLP-1 receptor agonists like semaglutide and tirzepatide do commonly produce gastrointestinal side effects including nausea, vomiting, constipation, and yes, sulfur-tasting burps caused by slowed gastric emptying. Davies et al. (2021, Diabetes Care) found that over 40% of semaglutide users reported nausea in clinical trials, mostly in the dose-escalation phase. This is consistent with the "body adapting" narrative. However, some side effects, including pancreatitis, gallbladder disease, and severe gastroparesis, are not adaptation signals. They require medical attention. Telling a large audience that side effects just mean your body is adapting is a reassurance that could delay people from flagging genuinely serious symptoms.

What did they get right and wrong in the caption?

Credit where it is due: the caption correctly identifies that common GLP-1 side effects are real, frequent, and often transient. That is accurate. "Phantom hunger," a term for psychological hunger cues that persist after appetite suppression, is a recognized patient-reported experience, though it lacks a standardized clinical definition. "Sulphur burps" are a plausible consequence of delayed gastric emptying, which GLP-1 drugs are known to cause (Camilleri, 2021, Gastroenterology).

The problem is the blanket reassurance. Not all side effects are benign adaptation. The FDA label for semaglutide includes warnings for thyroid C-cell tumors in rodents, pancreatitis, and diabetic retinopathy complications. Telling beginners that side effects "don't mean anything's gone wrong" without qualification is the kind of oversimplification that sounds supportive but could genuinely mislead someone ignoring a warning sign. A more honest framing would distinguish common transient effects from symptoms that warrant contacting a prescriber.

What should you actually know about GLP-1 side effects?

If you are starting a GLP-1 medication, here is what the evidence actually supports. Nausea and GI distress are common, especially during dose escalation, and do tend to improve over time for most patients. Eating smaller meals, avoiding high-fat foods, and staying hydrated are practical strategies with some clinical backing (Rubino et al., 2022, NEJM). Brain fog and fatigue, sometimes attributed to caloric restriction that accompanies appetite suppression, are patient-reported but not well-studied in controlled trials as direct drug effects.

The more important message is this: side effects exist on a spectrum. Mild nausea is different from persistent vomiting. Occasional fatigue is different from severe abdominal pain. Any symptom that is intense, worsening, or accompanied by other warning signs should be reported to your prescriber, not normalized away by social media framing. GLP-1 medications are prescription drugs managed through regulated clinical pathways for a reason.